earticle

논문검색

Evaluation of combined skin equivalents with gelatin and fibrin.

초록

영어

The main goal of this project is to study in vitro construction and in vivo application of combined skin substitutes based on the uses of cell populated gelatin and fibrin. We prepared skin equivalents with cell populated gelatin and fibrin, and then performed immunohistochemistry (IHC) analysis with bio-markers to evaluate the artificial skin in vitro and in vivo. Skin equivalent
models were prepared by combining gelatin-based dermal substitutes and fibrin-based cultured epithelium and by raising them up to the air-liquid interface. Skin substitute models were evaluated by marker proteins specific to individual dermis and epidermis. The basal membrane protein, type IV collagen and cytokeratin 14 were expressed in parallel with the basal layer protein on both skin substitute models. Also two spinous layer proteins, involucrin and
cytokerain 10 were stained. These results suggest that the skin equivalents combined with cell populated gelatin and fibrin differentiate well in vitro and in vivo and may be applicable as new skin substitutes.

저자정보

  • Hyo Jin Kim Biologics Headquarters, Korea Food and Drug Administration
  • Hye Na Kang Biologics Headquarters, Korea Food and Drug Administration
  • Ho Jung Oh Biologics Headquarters, Korea Food and Drug Administration
  • Soon Nam Kim Biologics Headquarters, Korea Food and Drug Administration
  • Pan Soon Kim Biologics Headquarters, Korea Food and Drug Administration
  • Young Lim Kim Biologics Headquarters, Korea Food and Drug Administration
  • Nae Ry Lee Biologics Headquarters, Korea Food and Drug Administration
  • Gwan Soo Kim Biologics Headquarters, Korea Food and Drug Administration
  • Min Joo Cho Biologics Headquarters, Korea Food and Drug Administration
  • Fu Shi Qaun The College of Veterinary Medicine, Konkuk University
  • Jong Hwan Lee The College of Veterinary Medicine, Konkuk University
  • Hong Ki Min Biologics Headquarters, Korea Food and Drug Administration
  • Seung Hwa Hong Biologics Headquarters, Korea Food and Drug Administration

참고문헌

자료제공 : 네이버학술정보

    함께 이용한 논문

      ※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.

      0개의 논문이 장바구니에 담겼습니다.